BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 32859133)

  • 21. Stromal expression of actin is a marker of aggressiveness in basal cell carcinoma.
    Adegboyega PA; Rodriguez S; McLarty J
    Hum Pathol; 2010 Aug; 41(8):1128-37. PubMed ID: 20381122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insight into imiquimod skin permeation and increased delivery using microneedle pre-treatment.
    Al-Mayahy MH; Sabri AH; Rutland CS; Holmes A; McKenna J; Marlow M; Scurr DJ
    Eur J Pharm Biopharm; 2019 Jun; 139():33-43. PubMed ID: 30771455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multivariate analysis strategies for processing ToF-SIMS images of biomaterials.
    Tyler BJ; Rayal G; Castner DG
    Biomaterials; 2007 May; 28(15):2412-23. PubMed ID: 17335898
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Collagen XVII/BP180 protein expression in squamous cell carcinoma of the skin detected with novel monoclonal antibodies in archived tissues using tissue microarrays and digital microscopy.
    Stelkovics E; Korom I; Marczinovits I; Molnar J; Rasky K; Raso E; Ficsor L; Molnar B; Kopper L; Krenacs T
    Appl Immunohistochem Mol Morphol; 2008 Oct; 16(5):433-41. PubMed ID: 18633319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spectral characterization of ten cyclic lipids using time-of-flight secondary ion mass spectrometry.
    Leefmann T; Heim C; Siljeström S; Blumenberg M; Sjövall P; Thiel V
    Rapid Commun Mass Spectrom; 2013 Mar; 27(5):565-81. PubMed ID: 23413216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Specific characteristics of skin basal cell carcinoma invasion].
    Doĭkova NG; Chernyĭ AP; Chipysheva TA; Gel'shteĭn VI
    Arkh Patol; 2000; 62(3):29-33. PubMed ID: 10897434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased glycosaminoglycans production in sclerosing basal cell carcinoma-derived fibroblasts and stimulation of normal skin fibroblast glycosaminoglycans production by a cytokine-derived from sclerosing basal cell carcinoma.
    Moy RL; Potter TS; Uitto J
    Dermatol Surg; 2000 Nov; 26(11):1029-36. PubMed ID: 11096389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biomarkers of basal cell carcinoma resistance to methyl-aminolevulinate photodynamic therapy.
    Gracia-Cazaña T; Mascaraque M; Lucena SR; Vera-Álvarez J; González S; Juarranz Á; Gilaberte Y
    PLoS One; 2019; 14(4):e0215537. PubMed ID: 31017970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigation of Silver Nanoparticle Induced Lipids Changes on a Single Cell Surface by Time-of-Flight Secondary Ion Mass Spectrometry.
    Hua X; Li HW; Long YT
    Anal Chem; 2018 Jan; 90(2):1072-1076. PubMed ID: 29260555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BerEP4-negative basal cell carcinoma on the palm: case report and review of the literature.
    Mleczko A; Franke I; Pokrywka A; Gollnick H; Leverkus M
    J Dtsch Dermatol Ges; 2011 Feb; 9(2):140-3. PubMed ID: 20629842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2.
    Zagrodnik B; Kempf W; Seifert B; Müller B; Burg G; Urosevic M; Dummer R
    Cancer; 2003 Dec; 98(12):2708-14. PubMed ID: 14669293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical evaluation of basal cell carcinoma and trichepithelioma using Bcl-2, Ki67, PCNA and P53.
    Abdelsayed RA; Guijarro-Rojas M; Ibrahim NA; Sangueza OP
    J Cutan Pathol; 2000 Apr; 27(4):169-75. PubMed ID: 10774937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential immunohistochemical expression of matrix metalloproteinase-10 (MMP-10) in non-melanoma skin cancers of the head and neck.
    Kadeh H; Saravani S; Heydari F; Shahraki S
    Pathol Res Pract; 2016 Oct; 212(10):867-871. PubMed ID: 27567711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cutaneous markers of photo-damage and risk of Basal cell carcinoma of the skin: a meta-analysis.
    Khalesi M; Whiteman DC; Doi SA; Clark J; Kimlin MG; Neale RE
    Cancer Epidemiol Biomarkers Prev; 2013 Sep; 22(9):1483-9. PubMed ID: 23833126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical nuclear staining for p53, PCNA, and Ki-67 in different histologic variants of basal cell carcinoma.
    Barrett TL; Smith KJ; Hodge JJ; Butler R; Hall FW; Skelton HG
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):430-7. PubMed ID: 9308559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Basal Cell Carcinoma Multiplicity - a Retrospective Analysis of 899 Biopsy-proven Patients from a Single Institute.
    Bartos V; Kullová M
    Klin Onkol; 2017; 30(3):197-201. PubMed ID: 28612616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipid analysis of eight human breast cancer cell lines with ToF-SIMS.
    Robinson MA; Graham DJ; Morrish F; Hockenbery D; Gamble LJ
    Biointerphases; 2015 Jun; 11(2):02A303. PubMed ID: 26319020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prognostic significance of tumor angiogenesis in nonaggressive and aggressive basal cell carcinoma of the human skin.
    Staibano S; Boscaino A; Salvatore G; Orabona P; Palombini L; De Rosa G
    Hum Pathol; 1996 Jul; 27(7):695-700. PubMed ID: 8698314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD10 expression in trichoepithelioma and basal cell carcinoma.
    Pham TT; Selim MA; Burchette JL; Madden J; Turner J; Herman C
    J Cutan Pathol; 2006 Feb; 33(2):123-8. PubMed ID: 16420307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of biomolecular distributions in rat brain tissues by means of ToF-SIMS using a continuous beam of Ar clusters.
    Nakano S; Yokoyama Y; Aoyagi S; Himi N; Fletcher JS; Lockyer NP; Henderson A; Vickerman JC
    Biointerphases; 2016 Jun; 11(2):02A307. PubMed ID: 26746166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.